GlassScriptPhysician profile
Jared M Mahylis
NPI 1700185154
$42,274.26
in general payments reported to CMS, 2019-2025
21 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,139 · 2020: $1,911 · 2021: $2,387 · 2022: $6,505 · 2023: $10K · 2024: $8,590 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Royalty Or License: $6,517 · Honoraria: $4,250 · Travel and Lodging: $2,291 · Food and Beverage: $2,025 · Grant: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,250.00 |
| Royalty Or License | $6,517.00 |
| Honoraria | $4,250.00 |
| Travel and Lodging | $2,291.31 |
| Food and Beverage | $2,024.54 |
| Grant | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fx Shoulder Solutions, INC | $24,004.40 | 2021-2025 | Fx V 135 Stem |
| Exactech, INC. | $10,285.74 | 2021-2025 | |
| Pinnacle, INC | $2,587.94 | 2021-2025 | |
| Medwest Associates | $2,581.84 | 2019-2020 | |
| Encore Medical, LP | $823.33 | 2019-2025 | Djo Surgical |
| Arthrex, INC. | $511.23 | 2024-2025 | |
| Depuy Synthes Sales INC. | $313.27 | 2019-2025 | Versalok Orthocord, Na |
| Stryker Corporation | $269.58 | 2021-2025 | Inspace, Aequalis Perform, Aequalis Flex Revive |
| Endo Pharmaceuticals INC. | $145.48 | 2019-2021 | |
| Shoulder Innovations, INC. | $141.65 | 2024 | Inset System |
| Next Science LLC | $124.74 | 2025 | Blastx, Xperience |
| Wright Medical Technology, INC. | $108.88 | 2019 | |
| Kci USA, INC. | $108.49 | 2019 | |
| Pacira Therapeutics, INC. | $101.94 | 2019-2021 | |
| Ermi LLC | $37.64 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $37.07 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Catalyst Orthoscience | $35.64 | 2021 | |
| Zimmer Biomet Holdings, INC. | $24.28 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.25 | 2019 | |
| Acumed LLC | $14.87 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Mahylis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.